Identification of a Homopolymer of 5-Acetamidino-7-acetamido-3,5,7,9-tetradeoxy-D-glycero-D-talo-nonulosonic Acid in the Lipopolysaccharides of Legionella pneumophila Non-1 Serogroups

被引:0
|
作者
Y. A. Knirel
S. N. Senchenkova
N. A. Kocharova
A. S. J. H. U. Shashkov
机构
[1] Russian Academy of Sciences,Zelinsky Institute of Organic Chemistry
[2] Center for Medicine and Biosciences,Research Center Borstel
[3] University Clinic of the Dresden Technical University,Institute of Medical Microbiology and Hygiene
来源
Biochemistry (Moscow) | 2001年 / 66卷
关键词
lipopolysaccharide; O-specific polysaccharide; structure; 5-acetamidino-7-acetamido-3,5,7; 9-tetradeoxy-D-glycero-D-talo-nonulosonic acid; legionaminic acid; Legionella pneumophila;
D O I
暂无
中图分类号
学科分类号
摘要
O-Specific polysaccharides (OPS) were isolated by mild acid hydrolysis of the lipopolysaccharides (LPS) of strainsof Legionella pneumophila serogroups 2-14, as well as strains Lansing 3 and 16453-92 from newly proposed serogroups. TheOPS were studied by 1H- and 13C-NMR spectroscopy, GLC/mass spectrometry, and chemical modifications (mild alkalineO-deacetylation and conversion of the N-acetimidoyl group into the N-acetyl group). All OPS were found to be ahomopolymer of a 5-acetamidino-7-acetamido-3,5,7,9-tetradeoxynonulosonic acid, which in some strains is 8-O-acetylat-ed. In most strains studied, the monosaccharide has the D-glycero-D-talo configuration and is thus the C4 epimer of legion-aminic acid (4-epilegionaminic acid), which has been previously identified as the monomer in the OPS of L. pneumophilaserogroup 1. Poly(4-epilegionaminic acid) occurs as a minor polysaccharide in serogroups 5 (strain Dallas 1) and 13 and isabsent in serogroups 1 and 7. The chemical basis for serological differentiation of L. pneumophila strains is discussed.
引用
收藏
页码:1035 / 1041
页数:6
相关论文
共 26 条
  • [21] Structure of the LPS O-chain from Fusobacterium nucleatum strain ATCC 23726 containing a novel 5,7-diamino-3,5,7,9-tetradeoxy-L-gluco-non-2-ulosonic acid presumably having the D-glycero-L-gluco configuration
    Vinogradov, Evgeny
    St Michael, Frank
    Cox, Andrew D.
    CARBOHYDRATE RESEARCH, 2018, 468 : 69 - 72
  • [22] Structure of the O-Antigen and Characterization of the O-Antigen Gene Cluster of Escherichia coli O108 Containing 5,7-Diacetamido-3,5,7,9-tetradeoxy-L-glycero-D-galacto-non-2-ulosonic (8-Epilegionaminic) Acid
    Perepelov, A. V.
    Liu, Bin
    Senchenkova, S. N.
    Shashkov, A. S.
    Shevelev, S. D.
    Feng, Lu
    Wang, Lei
    Knirel, Y. A.
    BIOCHEMISTRY-MOSCOW, 2010, 75 (01) : 19 - 24
  • [23] Structure of the O-polysaccharide of Escherichia coli O61, Another E. coli O-antigen That Contains 5,7-Diacetamido-3,5,7,9-tetradeoxy-L-glycero-D-galacto-non-2-ulosonic (Di-N-acetyl-8-epilegionaminic) Acid
    Perepelov, Andrei V.
    Wang, Quan
    Liu, Bin
    Senchenkova, Sof'ya N.
    Feng, Lu
    Shashkov, Alexander S.
    Wang, Lei
    Knirel, Yuriy A.
    JOURNAL OF CARBOHYDRATE CHEMISTRY, 2009, 28 (7-8) : 463 - 472
  • [24] Identification of a novel sugar 5,7-diacetamido-8-amino-3,5,7,8,9-pentadeoxy-d-glycero-d-galacto-non-2-ulosonic acid present in the lipooligosaccharide of Vibrio parahaemolyticus O3:K6
    Koushik Mazumder
    Biswa P. Choudhury
    G. Balakrish Nair
    Asish K. Sen
    Glycoconjugate Journal, 2008, 25 : 345 - 354
  • [25] Identification of a novel sugar 5,7-diacetamido-8-amino-3,5,7,8,9-pentadeoxy-D-glycero-D-galacto-non-2-ulosonic acid present in the lipooligosaccharide of Vibrio parahaemolyticus O3: K6
    Mazumder, Koushik
    Choudhury, Biswa P.
    Nair, G. Balakrish
    Sen, Asish K.
    GLYCOCONJUGATE JOURNAL, 2008, 25 (04) : 345 - 354
  • [26] Characterization of two novel N-methyl-D-aspartate antagonists:: EAA-090 (2-[8,9-dioxo-2,6-diazabicyclo [5.2.0]non-1(7)-en2-yl]ethylphosphonic acid) and EAB-318 (R-α-amino-5-chloro-1-(phosphonomethyl)-1H-benzimidazole-2-propanoic acid hydrochloride)
    Sun, L
    Chiu, D
    Kowal, D
    Simon, R
    Smeyne, M
    Zukin, RS
    Olney, J
    Baudy, R
    Lin, S
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 310 (02): : 563 - 570